Cara Therapeutics, Inc. (CARA) has 109 open-market insider trades by 16 insiders since 2014. The most active filer is Derek T. Chalmers, CEO & President.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Mark Leschly | 10% Owner | — | 2 | $11.6M | 2017-03-31 |
| Dean Slagel | Dir | — | 3 | $9.6M | 2017-06-29 |
| Derek T. Chalmers | CEOPres | — | 37 | $7.2M | 2021-09-07 |
| Martin Vogelbaum | Dir | — | 5 | $6.7M | 2024-06-04 |
| Frederique Menzaghi Ph.D. | VP | — | 28 | $4.3M | 2024-02-01 |
| Mani Mohindru | CFOCSO | — | 7 | $2.1M | 2019-12-04 |
| RHO Ventures VI LP via Martin Vogelbaum | 10% Owner | — | 1 | $1.9M | 2016-03-17 |
| Edward Hurwitz | Dir10% | — | 1 | $1.2M | 2014-02-05 |
| Jeffrey L. Ives | Dir | — | 7 | $589K | 2024-06-04 |
| Joana Goncalves | — | — | 6 | $485K | 2024-04-05 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Christopher Posner | President | Sell | $3K | 2025-02-28 |
| Scott Terrillion | SEC'Y & CHIEF COMPLIANCE & G.C. | Sell | $776 | 2025-02-28 |
| Christopher Posner | President | Sell | $2K | 2025-02-04 |
| Christopher Posner | President | Sell | $1K | 2024-11-04 |
| Christopher Posner | President | Sell | $1K | 2024-08-01 |
| Christopher Posner | President | Sell | $3K |
Companies that share insiders with CARA, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2024-05-02 |
| Scott Terrillion | SEC'Y & CHIEF COMPLIANCE & G.C. | Sell | $2K | 2024-04-05 |
| Scott Terrillion | SEC'Y & CHIEF COMPLIANCE & G.C. | Sell | $3K | 2024-02-29 |
| Christopher Posner | President | Sell | $5K | 2024-02-29 |
| Christopher Posner | President | Sell | $19K | 2024-02-08 |
| Christopher Posner | President | Sell | $3K | 2024-02-01 |
| Christopher Posner | President | Sell | $5K | 2023-11-02 |
| Christopher Posner | President | Sell | $13K | 2023-08-03 |
| Scott Terrillion | Sec'y & Chief Compliance & G.C. | Sell | $9K | 2023-06-23 |
| Joana Goncalves | Chief Medical Officer | Sell | $10K | 2023-06-23 |